NL8601188A - Morfinanderivaten, therapeutische preparaten die deze derivaten bevatten en werkwijzen voor het bereiden van deze derivaten. - Google Patents

Morfinanderivaten, therapeutische preparaten die deze derivaten bevatten en werkwijzen voor het bereiden van deze derivaten. Download PDF

Info

Publication number
NL8601188A
NL8601188A NL8601188A NL8601188A NL8601188A NL 8601188 A NL8601188 A NL 8601188A NL 8601188 A NL8601188 A NL 8601188A NL 8601188 A NL8601188 A NL 8601188A NL 8601188 A NL8601188 A NL 8601188A
Authority
NL
Netherlands
Prior art keywords
group
compound
formula
carbon atoms
compounds
Prior art date
Application number
NL8601188A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8601188A publication Critical patent/NL8601188A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL8601188A 1985-05-23 1986-05-12 Morfinanderivaten, therapeutische preparaten die deze derivaten bevatten en werkwijzen voor het bereiden van deze derivaten. NL8601188A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23
DE3518525 1985-05-23

Publications (1)

Publication Number Publication Date
NL8601188A true NL8601188A (nl) 1986-12-16

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601188A NL8601188A (nl) 1985-05-23 1986-05-12 Morfinanderivaten, therapeutische preparaten die deze derivaten bevatten en werkwijzen voor het bereiden van deze derivaten.

Country Status (18)

Country Link
JP (1) JPS61271275A (fi)
AU (1) AU594954B2 (fi)
BE (1) BE904796A (fi)
DK (1) DK240386A (fi)
ES (1) ES8802318A1 (fi)
FI (1) FI862124A (fi)
FR (1) FR2582309B1 (fi)
GB (1) GB2175898B (fi)
GR (1) GR861318B (fi)
HU (1) HU196376B (fi)
IL (1) IL78872A0 (fi)
IT (1) IT1203791B (fi)
LU (1) LU86435A1 (fi)
NL (1) NL8601188A (fi)
NZ (1) NZ216250A (fi)
PH (1) PH23341A (fi)
SE (1) SE8602308L (fi)
ZA (1) ZA863873B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
NZ246687A (en) * 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof
KR100341950B1 (ko) * 1993-07-19 2002-11-29 도레이 가부시끼가이샤 뇌세포보호제
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
DE69717967T2 (de) 1996-01-10 2003-08-28 Glaxosmithkline Spa Heterocyclische kondensierte morphin-derivate
ATE263563T1 (de) * 1996-11-25 2004-04-15 Toray Industries Mittel gegen juckreiz
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
AU2003234621A1 (en) 2002-05-17 2003-12-02 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4957489B2 (ja) * 2002-10-09 2012-06-20 東レ株式会社 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8354534B2 (en) 2008-02-14 2013-01-15 Alkermes, Inc. Selective opioid compounds
ES2621305T3 (es) * 2012-12-14 2017-07-03 Purdue Pharma Lp Morfinanos espirocíclicos y su uso
ES2631197T3 (es) * 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes
AR096851A1 (es) * 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
EP3154972A4 (en) * 2014-06-13 2017-11-22 Purdue Pharma L.P. Azamophinan derivatives and use thereof

Also Published As

Publication number Publication date
FI862124A (fi) 1986-11-24
IT1203791B (it) 1989-02-23
AU5763786A (en) 1986-11-27
GB2175898B (en) 1989-07-05
ES8802318A1 (es) 1988-05-01
JPS61271275A (ja) 1986-12-01
AU594954B2 (en) 1990-03-22
DK240386D0 (da) 1986-05-22
NZ216250A (en) 1990-04-26
FI862124A0 (fi) 1986-05-21
ES555200A0 (es) 1988-05-01
LU86435A1 (fr) 1986-12-05
PH23341A (en) 1989-07-14
BE904796A (fr) 1986-11-21
HUT41737A (en) 1987-05-28
GB2175898A (en) 1986-12-10
FR2582309A1 (fr) 1986-11-28
DK240386A (da) 1986-11-24
ZA863873B (en) 1988-01-27
FR2582309B1 (fr) 1989-08-18
GB8612159D0 (en) 1986-06-25
HU196376B (en) 1988-11-28
GR861318B (en) 1986-09-19
IT8648050A0 (it) 1986-05-23
SE8602308L (sv) 1986-11-24
SE8602308D0 (sv) 1986-05-21
IL78872A0 (en) 1986-09-30

Similar Documents

Publication Publication Date Title
NL8601188A (nl) Morfinanderivaten, therapeutische preparaten die deze derivaten bevatten en werkwijzen voor het bereiden van deze derivaten.
US4912114A (en) Morphinan derivatives
EP0179383B1 (en) 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
DK172103B1 (da) Hidtil ukendte 3,3-difenylpropylaminer, farmaceutiske præparater indeholdende disse, deres anvendelse til fremstilling af et anticholinergt lægemiddel samt fremgangsmåde til deres fremstilling
PL108465B1 (en) Method of producing new 1,3,4-trisubstituted 4-arylopiperidines
Wikstroem et al. Monophenolic octahydrobenzo [f] quinolines: central dopamine-and serotonin-receptor stimulating activity
US4272540A (en) 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
US3950527A (en) N-[ω-(4'-(3"-indolyl)-piperidino)-alkyl]-benzamides
US4692453A (en) Pharmaceutical active 1,2,3,4,4A,5,10,10A-octahydrobenzo[g] quinoline derivatives, and their use
EP1248770A1 (en) 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
NZ195329A (en) 6,7-benzomorphan derivatives and pharmaceutical compositions
EP0233049A1 (en) 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd]azepines
NO154391B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater.
EP0209275B1 (en) Benz-trisubstituted 2-aminotetralins
CA2005547C (en) Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones
Radl et al. Synthesis of piperidine analogs of 1‐(3‐chlorophenyl) piperazine, a well known serotonin ligand
EP0033632A2 (en) 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
US4301290A (en) Organic compounds
NO147911B (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest
NZ235815A (en) Substituted 8-(2-morpholinylmethoxy)-1,2,3,4-tetrahydroquinoline derivatives and pharmaceutical compositions
EP0746556B1 (en) Tricyclic compounds having affinity for the 5-ht1a receptor
PL108916B1 (en) Method of producing new derivatives of trans-5a-arylodecahydrobenzazepine
GB2117771A (en) Enantiomers of substituted phenylazacycloalkanes
DE3617182A1 (de) Morphinan-derivate
PAIN United States Patent po

Legal Events

Date Code Title Description
BV The patent application has lapsed